Indefinite Delivery Contract 36C25524D0411
Award Date
6/1/24
Last Date to Order
5/31/29
Federal Agency
Veterans Integrated Service Network 15
Awardee
Sofie CO.
Ultimate Awardee
Not listed
NAICS Category
325412 - Pharmaceutical Preparation Manufacturing
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Pricing Type
Firm Fixed Price
Legislative Mandate
Service Contract Inventory
National Interest Action
None
Award Type
Single
Primary Consortia Member
Not listed
Similar IDVs
Sofie Co. was awarded an indefinite delivery contract from the Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 12 to provide radiopharmaceuticals. The contract has a potential value of $209,760 and period of performance through July 2022. Sofie was issued two firm fixed price delivery orders against the VHA Pharmaceutical Prime Vendor contract totaling $537,032.67 to supply Pylarify Piflufolastat F18 for use in positron emission tomography...
This federal contract Indefinite Delivery Vehicle (IDV) was awarded by the Department of Veterans Affairs (VA) Veterans Integrated Service Network 17 (VISN 17) to Sofie CO., a subsidiary of Sofie Biosciences, Inc. The $2,345,668 Firm Fixed Price contract has an ultimate completion date of August 31, 2029 and was awarded on September 1, 2024.
The contract is for the delivery of PYLARIFY (piflufolastat F-18) isotopes, which are used for prostate cancer detection through positron emission...
The Department of Veterans Affairs Veterans Health Administration awarded a blanket purchase agreement to Sofie CO., doing business as Sofie and subsidiary of Sofie Biosciences, Inc., to provide radiopharmaceutical products and services in support of nuclear medicine diagnostic services for veterans. The single award contract, valued at up to $500,000, has a period of performance from October 1, 2022 through March 31, 2024.
Two calls have been issued against the blanket purchase agreement....
This federal contract Indefinite Delivery Vehicle (IDV) was awarded by the Department of Veterans Affairs (VA) Veterans Integrated Service Network (VISN) 15 to Sofie CO., a subsidiary of Sofie Biosciences, Inc. The $1,009,490.10 single-award IDV covers the supply of the F-18 PYLARIFY (piflufolastat F-18) prostate-specific membrane agent radiopharmaceutical and related services from September 2022 through August 2025, with four one-year option periods.
Under this IDV, the VA has issued...
The Department of Veterans Affairs Veterans Integrated Service Network 10 (VA VISN 10) awarded a single-award indefinite delivery contract to Sofie CO., a subsidiary of Sofie Biosciences, to provide radiopharmaceutical PET imaging products and services. The $1.3 million contract, with a period of performance from October 2021 through September 2026, supports the VA's diagnostics and cancer treatment programs for veterans across the VISN 10 region.
The contract requires Sofie to deliver...
The federal contract IDV award in this case was issued by the Department of Veterans Affairs' Veterans Integrated Service Network 2 (VISN 2) to Sofie CO., a subsidiary of Sofie Biosciences, Inc. The IDV has a ceiling value of $6,282,459.40 and is focused on the procurement of PYLARIFY (piflufolastat F-18), a radiopharmaceutical used for prostate cancer detection, as well as other PET imaging agents such as FDG (fluorodeoxyglucose) and NEURACEQ (florbetaben F-18).
The IDV has facilitated...
This federal contract IDV, awarded by the Department of Veterans Affairs (VA) Veterans Integrated Service Network 2, is for the supply of PET radiopharmaceuticals to the Buffalo VA Medical Center. The $1.9 million single-award IDV was granted to Sofie CO., a for-profit subsidiary of Sofie Biosciences, Inc. that specializes in radiopharmaceuticals and PET imaging agents. The initial $635,896.40 delivery order under this IDV covers the supply of five specific radiopharmaceuticals: FDG, Cu64...
The Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 15 awarded a single award Blanket Purchase Agreement to Sofie CO., doing business as Sofie, for PYLARIS products and services. The BPA has a potential value of $316,221.30 and a period of performance from March 4, 2022 through March 3, 2023.
Additionally, the VA - VHA awarded a BPA Call contract to Sofie CO. for $1,062,076.02 utilizing a firm fixed price contract type. The award provides...
Sofie CO. has been awarded a blanket purchase agreement by the Defense Health Agency to provide radiopharmaceuticals to various military treatment facilities. The single award BPA has a potential value of $700,000 and period of performance through September 2025. Sofie will supply specialized molecular imaging agents to support diagnostic imaging programs at locations including Fort Sam Houston in Texas.
Three calls have been placed against the BPA. In September 2023, Sofie received a $40,800...
The Defense Health Agency awarded a blanket purchase agreement indefinite-delivery/indefinite-quantity contract to Sofie CO, doing business as Sofie, with a potential value of $6.5 million. Task orders issued against the contract by the Agency call for Sofie to provide various radiopharmaceuticals and pharmaceutical products to support the Agency's medical treatment facilities and programs. Delivery locations include Sterling, Virginia and Bethesda, Maryland. The orders specify needs for...